555 related articles for article (PubMed ID: 33883243)
21. Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness.
Mechineni A; Kassab H; Manickam R
Expert Opin Drug Saf; 2021 Nov; 20(11):1299-1307. PubMed ID: 34338121
[TBL] [Abstract][Full Text] [Related]
22. Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
Rocca E; Gauffin O; Savage R; Vidlin SH; Grundmark B
Drug Saf; 2021 Sep; 44(9):987-998. PubMed ID: 34374967
[TBL] [Abstract][Full Text] [Related]
23. Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.
Biancalana E; Chiriacò M; Sciarrone P; Mengozzi A; Mechelli S; Taddei S; Solini A
Clin Interv Aging; 2021; 16():1037-1046. PubMed ID: 34113086
[TBL] [Abstract][Full Text] [Related]
24. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
Montastruc F; Thuriot S; Durrieu G
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
[TBL] [Abstract][Full Text] [Related]
25. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Chao JY; Derespina KR; Herold BC; Goldman DL; Aldrich M; Weingarten J; Ushay HM; Cabana MD; Medar SS
J Pediatr; 2020 Aug; 223():14-19.e2. PubMed ID: 32407719
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
Trials; 2020 May; 21(1):422. PubMed ID: 32448345
[TBL] [Abstract][Full Text] [Related]
28. Remdesivir for the treatment of COVID-19: a living systematic review.
Verdugo-Paiva F; Acuña MP; Solá I; Rada G;
Medwave; 2020 Dec; 20(11):e8080. PubMed ID: 33361753
[TBL] [Abstract][Full Text] [Related]
29. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis.
Rezagholizadeh A; Khiali S; Sarbakhsh P; Entezari-Maleki T
Eur J Pharmacol; 2021 Apr; 897():173926. PubMed ID: 33549577
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
[No Abstract] [Full Text] [Related]
31. A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone.
Jo YH; Hwang Y; Choi SH
J Korean Med Sci; 2021 Jul; 36(29):e203. PubMed ID: 34313036
[TBL] [Abstract][Full Text] [Related]
32. A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel.
Goldberg E; Ben Zvi H; Sheena L; Sofer S; Krause I; Sklan EH; Shlomai A
Clin Microbiol Infect; 2021 Jun; 27(6):917.e1-917.e4. PubMed ID: 33705849
[TBL] [Abstract][Full Text] [Related]
33. Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
Kaka AS; MacDonald R; Greer N; Vela K; Duan-Porter W; Obley A; Wilt TJ
Ann Intern Med; 2021 May; 174(5):663-672. PubMed ID: 33560863
[TBL] [Abstract][Full Text] [Related]
34. Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Hong YN; Xu J; Sasa GBK; Zhou KX; Ding XF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):541-548. PubMed ID: 33506946
[TBL] [Abstract][Full Text] [Related]
35. Remdesivir for patients with COVID-19.
Wu PE; Morris AM
CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097
[No Abstract] [Full Text] [Related]
36. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R; Kansagara DL; Marcucci M
Ann Intern Med; 2021 Feb; 174(2):229-236. PubMed ID: 33017175
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study.
Joo EJ; Ko JH; Kim SE; Kang SJ; Baek JH; Heo EY; Shi HJ; Eom JS; Choe PG; Bae S; Ra SH; Kim DY; Kim BN; Kang YM; Kim JY; Chung JW; Chang HH; Bae S; Cheon S; Park Y; Choi H; Lee E; Lee BY; Park JW; Sohn Y; Heo JY; Kim SH; Peck KR
J Korean Med Sci; 2021 Mar; 36(11):e83. PubMed ID: 33754512
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection - a single-center, retrospective, cohort study.
Kautsch K; Wiśniowska J; Friedman-Gruszczyńska J; Buda P
Eur J Pediatr; 2024 Feb; 183(2):591-598. PubMed ID: 37864601
[TBL] [Abstract][Full Text] [Related]
39. Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence.
Lin HXJ; Cho S; Meyyur Aravamudan V; Sanda HY; Palraj R; Molton JS; Venkatachalam I
Infection; 2021 Jun; 49(3):401-410. PubMed ID: 33389708
[TBL] [Abstract][Full Text] [Related]
40. Remdesivir: treatment of COVID-19 in special populations.
Molaei E; Molaei A; Hayes AW; Karimi G
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3829-3855. PubMed ID: 38180557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]